Pr ecis: Tumor pathogenesis relies upon PI3K⁄Akt signaling not only in tumor cells but also in cells of the tumor microenvironment, as shown here in cancer-associated fibroblasts through a mechanism involving activation of an actin-binding protein that drives the invasive behavior of nearby cancer cells.
Pr ecis: This study identifies a protease responsible for trimming MHC class I-bound peptides in cancer cells as a target for regulating NK-cell immunity, with implications for improving outcomes of NK cell-based immunotherapeutic strategies. 
ABOUT THE COVER
The high concentration of extracellular ATP in inflammatory lesions activates the purinergic P2RX7 receptor, which is expressed on immune and nonimmune cells of the gastrointestinal tract. The P2RX7 receptor participates in the initiation as well as the regulation of the inflammatory response and consequently can favor colon carcinogenesis. Using both genetic and pharmacological models of P2RX7 inactivation, we found that P2RX7 acted at an early stage to suppress the development of colitis-associated cancer. For details, see the article by Hofman and colleagues on page 835. To request permission to re-use all or part of this article, contact the AACR Publications Department at
